Thursday, June 5, 2014
4:00 pm – 6:00 pm
Anlyan Center at Yale
300 Cedar Street
New Haven, CT
At this CURE annual meeting, a diverse team of experts active in connecting and growing Connecticut bioscience will share their recent experience and news.
We will hear about some of Yale’s bioscience-related policy strategies from Richard Jacob. Harry Penner will share his recent on-the-ground experiences getting to funding a series of biotech companies, including for example, NewHaven Pharma. Frank Marco will consider themes about company needs and problems as he supports investors, start-ups, universities and growing businesses alike. Peter Farina will discuss perspectives for healthcare investments and how this applies to Connecticut’s bioscience cluster.
Moderated by Susan Froshauer, President and CEO of CURE. Click on names below for speaker biographies.
Harry Penner, CURE Executive Committee
Peter Farina, Co-chair and Board Member of CURE, Executive in Residence at Canaan Partners, Managing Partner of Salient Science & Technology, LLC
Richard Jacob, CURE Executive Committee, Yale’s Associate Vice President for Federal Relations
Frank Marco, Secretary of CURE, Executive Committee, Partner at Wiggin and Dana’s Coporate Practice Department